BB
Balram Bhargava
About Balram Bhargava
Data last updated:
Balram Bhargava is a Director at Cipla Limited (since 2024), Director at Molbio Diagnostics Limited (since 2024) and Director at Molbio Diagnostics Limited (since 2024). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹30,073 Cr; the largest is Cipla Limited at ₹29,045 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2024 | 1935 | ₹29,045 Cr (FY 2026) | Active | |
| Director | 16 Nov 2024 | 2000 | ₹1,028 Cr (FY 2025) | Active | |
| Director | 16 Nov 2024 | 2000 | Active |
Board colleagues of Balram Bhargava
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Balram Bhargava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Balram Bhargava
Balram Bhargava currently holds 3 directorships: Cipla Limited (Director, since 01 Apr 2024, revenue ₹29,045 Cr (FY 2026)); Molbio Diagnostics Limited (Director, since 16 Nov 2024, revenue ₹1,028 Cr (FY 2025)); Molbio Diagnostics Limited (Director, since 16 Nov 2024).
Balram Bhargava was first appointed on 01 Apr 2024 as Director at Cipla Limited.
The 2 current companies of Balram Bhargava that report revenue have a combined latest revenue of ₹30,073 Cr: Cipla Limited ₹29,045 Cr (FY 2026); Molbio Diagnostics Limited ₹1,028 Cr (FY 2025).
The current boards of Balram Bhargava's companies include Abhijit Jagdish Joshi (Cipla Limited), Achin Gupta (Cipla Limited), Achin Gupta (Cipla Limited), Adil Zainulbhai (Cipla Limited), Dinesh Ramniranjan Jain (Cipla Limited), Kamil Hamied (Cipla Limited), among others.